Sputum phagocytes from healthy individuals are functional and activated: a flow cytometric comparison with cells in bronchoalveolar lavage and peripheral blood.

Cells in the bronchial airways of healthy individuals are continuously exposed to inhaled particulates in the size range 2-5 microm, which preferentially deposit in the bronchial rather than the alveolar lung. Induced sputum obtains cells primarily from the surfaces of bronchial airways. Using flow cytometry, we investigated whether sputum phagocytes demonstrate phenotypes indicative of increased functional activation and inflammation compared to phagocytes from the alveolar airways and peripheral blood (PB) in healthy subjects (N = 17). Sputum macrophages demonstrated increased levels of CD11b, increased oxidative burst, and greater phagocytosis than autologous alveolar macrophages. Expression of CD11b, CD64, and HLA-DR in sputum monocytes was upregulated compared to that in PB monocytes. Sputum neutrophils showed increased expression of CD11b, CD64, CD14, and HLA-DR and were more phagocytic than PB neutrophils. In conclusion sputum/bronchial phagocytes from healthy individuals express an inflammatory phenotype and are functionally more active than phagocytes from the alveolar airways and peripheral blood.

[1]  C. Haslett.  Granulocyte apoptosis and its role in the resolution and control of lung inflammation. , 1999, American journal of respiratory and critical care medicine.

[2]  C. Monn,et al.  Cytotoxicity and induction of proinflammatory cytokines from human monocytes exposed to fine (PM2.5) and coarse particles (PM10-2.5) in outdoor and indoor air. , 1999, Toxicology and applied pharmacology.

[3]  R. Rylander,et al.  Inflammatory response after inhalation of bacterial endotoxin assessed by the induced sputum technique , 1998, Thorax.

[4]  Azuma,et al.  Expression of B7 co‐stimulatory molecules and CD1a antigen by alveolar macrophages in allergic bronchial asthma , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  D. Payen,et al.  ALVEOLAR NEUTROPHIL OXIDATIVE BURST AND β2 INTEGRIN: EXPRESSION IN EXPERIMENTAL ACUTE PULMONARY INFLAMMATION ARE NOT MODIFIED BY INHALED NITRIC OXIDE , 1998, Shock.

[6]  K. Chung,et al.  Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects , 1998, Thorax.

[7]  E. Bel,et al.  CD11b and L‐selectin expression on eosinophils and neutrophils in blood and induced sputum of patients with asthma compared with normal subjects , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[8]  W. Luttmann,et al.  CD14 expression and soluble CD14 after segmental allergen provocation in atopic asthma. , 1998, The European respiratory journal.

[9]  T. Pearson,et al.  Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64. , 1998, Blood.

[10]  D. Rodeberg,et al.  Azurophilic granules of human neutrophils contain CD14 , 1997, Infection and immunity.

[11]  R. Sergysels,et al.  Dose-response relationship to inhaled endotoxin in normal subjects. , 1997, American journal of respiratory and critical care medicine.

[12]  P. Sterk,et al.  Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[13]  F. Hargreave,et al.  Induced sputum cell and fluid-phase indices of inflammation: comparison of treatment with dithiothreitol vs phosphate-buffered saline. , 1997, The European respiratory journal.

[14]  P. Barnes,et al.  Cellular profiles in asthmatic airways: a comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid. , 1997, Thorax.

[15]  T. Martin.  Leukocyte migration and activation in the lungs. , 1997, The European respiratory journal.

[16]  M. C. Liu,et al.  Phenotypic analysis of alveolar macrophages and monocytes in allergic airway inflammation. I. Evidence for activation of alveolar macrophages, but not peripheral blood monocytes, in subjects with allergic rhinitis and asthma. , 1997, American journal of respiratory and critical care medicine.

[17]  C. Kim,et al.  Assessment of regional deposition of inhaled particles in human lungs by serial bolus delivery method. , 1996, Journal of applied physiology.

[18]  F. Hargreave,et al.  Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. , 1996, American journal of respiratory and critical care medicine.

[19]  M. Sears,et al.  Elevated B cells in sputum of asthmatics. Close correlation with eosinophils. , 1996, American journal of respiratory and critical care medicine.

[20]  L. Fabbri,et al.  Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. , 1995, American journal of respiratory and critical care medicine.

[21]  H. Kubo,et al.  Adhesion molecule CD18 on polymorphonuclear cells correlates to the lung injury caused by continuous infusion of endotoxin in sheep. , 1995, The Tohoku journal of experimental medicine.

[22]  P. Detmers,et al.  Endotoxin receptors (CD14) are found with CD16 (Fc gamma RIII) in an intracellular compartment of neutrophils that contains alkaline phosphatase. , 1995, Journal of immunology.

[23]  P. Parsons,et al.  Neutrophil response to endotoxin in the adult respiratory distress syndrome: role of CD14. , 1995, American journal of respiratory cell and molecular biology.

[24]  A. Imrich,et al.  Flow cytometric assay of lung macrophage uptake of environmental particulates. , 1995, Cytometry.

[25]  Kwang Woo Kim,et al.  Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. , 1995, The Journal of allergy and clinical immunology.

[26]  D. Postma,et al.  Lymphocyte and macrophage activation in bronchoalveolar lavage fluid in nocturnal asthma. , 1995, American journal of respiratory and critical care medicine.

[27]  P. Detmers,et al.  Different signaling pathways for CD18-mediated adhesion and Fc-mediated phagocytosis. Response of neutrophils to LPS. , 1994, Journal of immunology.

[28]  A. Komiyama,et al.  Pentoxifylline and CD14 antibody additively inhibit priming of polymorphonuclear leukocytes for enhanced release of superoxide by lipopolysaccharide: possible mechanism of these actions , 1994, Infection and immunity.

[29]  G. Downey,et al.  Neutrophils increase volume during migration in vivo and in vitro. , 1994, American journal of respiratory cell and molecular biology.

[30]  M. Konstan,et al.  Tissue-Specific Fc γ and Complement Receptor Expression by Alveolar Macrophages Determines Relative Importance of IgG and Complement in Promoting Phagocytosis of Pseudomonas aeruginosa , 1994, Pediatric Research.

[31]  M. Hoekstra,et al.  Expression of CD35 (CR1) and CD11b (CR3) on circulating neutrophils and eosinophils from allergic asthmatic children , 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[32]  B. Passlick,et al.  The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages , 1993, European journal of immunology.

[33]  M. Luchi,et al.  Binding, internalization, and deacylation of bacterial lipopolysaccharide by human neutrophils. , 1993, Journal of immunology.

[34]  John I. Gallin,et al.  Inflammation: Basic Principles and Clinical Correlates , 1992 .

[35]  S. Georas,et al.  Altered adhesion molecule expression and endothelial cell activation accompany the recruitment of human granulocytes to the lung after segmental antigen challenge. , 1992, American journal of respiratory cell and molecular biology.

[36]  J. Bousquet,et al.  Comparison between bronchial and alveolar samples of bronchoalveolar lavage fluid in asthma. , 1992, Chest.

[37]  P. O'Byrne,et al.  Changes in the cellular profile of induced sputum after allergen-induced asthmatic responses. , 1992, The American review of respiratory disease.

[38]  D. Golde,et al.  Activation of human eosinophil and neutrophil functions by haematopoietic growth factors: comparisons of IL‐1, IL‐3, IL‐5 and GM‐CSF , 1992, British journal of haematology.

[39]  W. Calhoun,et al.  Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronchoprovocation in allergic subjects. , 1992, The American review of respiratory disease.

[40]  R. Kimberly,et al.  Functional capacity of Fcγ receptor III (CD16) on human neutrophils , 1992 .

[41]  J. Bousquet,et al.  Increased numbers of hypodense alveolar macrophages in patients with bronchial asthma. , 1991, The American review of respiratory disease.

[42]  S. Wright,et al.  Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14 , 1991, The Journal of experimental medicine.

[43]  S. Wright,et al.  Multiple receptors for endotoxin. , 1991, Current opinion in immunology.

[44]  S. Becker,et al.  Antagonistic and additive effects of IL-4 and interferon-gamma on human monocytes and macrophages: effects on Fc receptors, HLA-D antigens, and superoxide production. , 1990, Cellular immunology.

[45]  H. Rosen,et al.  The role of the type 3 complement receptor in the induced recruitment of myelomonocytic cells to inflammatory sites in the mouse. , 1990, American journal of respiratory cell and molecular biology.

[46]  D. Dearborn,et al.  Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. , 1989, The Journal of clinical investigation.

[47]  M. Walport,et al.  Expression of complement receptors type 1 (CR1) and type 3 (CR3) on circulating granulocytes in experimentally provoked asthma. , 1989, The Journal of allergy and clinical immunology.

[48]  N. Hogg,et al.  The Fc receptor, FcRI, and other activation molecules on human mononuclear phagocytes after treatment with interferon-gamma. , 1989, Clinical and experimental immunology.

[49]  H. Lassmann,et al.  Expression of the VEP13 antigen (CD16) on native human alveolar macrophages and cultured blood monocytes. , 1988, Immunobiology.

[50]  C. Figdor,et al.  Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4. , 1988, Journal of immunology.

[51]  M. Stempniak,et al.  Ability of peripheral blood neutrophils from patients with infectious bronchial asthma to engulf latex particles and reduce nitroblue tetrazolium. , 1988, Archivum immunologiae et therapiae experimentalis.

[52]  T. Ferro,et al.  Differential Prostaglandin Production by Unfractionated and Density‐Fractionated Human Monocytes and Alveolar Macrophages , 1987, Journal of leukocyte biology.

[53]  T. Ferro,et al.  Alveolar macrophages, blood monocytes, and density-fractionated alveolar macrophages differ in their ability to promote lymphocyte proliferation to mitogen and antigen. , 1987, The American review of respiratory disease.

[54]  R. Matusiewicz,et al.  The ability of granulocytes from patients with atopy to engulf neutral latex particles and Staphylococcus aureus. , 1987, Archivum immunologiae et therapiae experimentalis.

[55]  J. Bonde,et al.  Association of defective monocyte chemotaxis with recurrent acute exacerbations in chronic obstructive lung disease. , 1986, European journal of respiratory diseases.

[56]  Z. Cohn,et al.  The alveolar macrophage. , 1986, Journal of applied physiology.

[57]  T. Lindmo,et al.  Flow cytometry and sorting , 1979 .